Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (303)
ARTG (234)
Prescription medicine registration (15)

Date

2024 (31)
2023 (161)
2022 (28)
2021 (55)
2020 (48)
2019 (26)
2018 (52)
2017 (35)
2016 (78)
2014 (2)
2013 (9)
2012 (16)
2011 (2)
2010 (9)

Results for "[search-keyword]"

Search

Sponsor content

552 result(s) found, displaying 371 to 380

ESCITALOPRAM-DRLA escitalopram (as oxalate) 20mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
PEMETREXED-DRLA pemetrexed (as disodium) 100 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
SILDENAFIL-DRLA Sildenafil (as citrate) 25 mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
SILDENAFIL-DRLA Sildenafil (as citrate) 50 mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
RABEPRAZOLE-DRLA rabeprazole sodium 20mg enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
RABEPRAZOLE-DRLA rabeprazole sodium 10mg enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ROSUVASTATIN-DRLA rosuvastatin (as calcium) 40 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ROSUVASTATIN-DRLA rosuvastatin (as calcium) 10 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ROSUVASTATIN-DRLA rosuvastatin (as calcium) 5 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ROSUVASTATIN-DRLA rosuvastatin (as calcium) 20 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd

Pages

First page
Previous page
…
Page 34
Page 35
Page 36
Page 37
Current page 38
Page 39
Page 40
Page 41
Page 42
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.